- Home
- / Konruns Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Konruns Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥23.8
2024-10-29
Market Capitalization
¥3.7 B
2024-10-29
Revenue
¥903.4 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 955.9M | 1.1B | 796.8M | 684.3M | 844.5M | 911.9M | 817.7M | 903.4M |
| Cost of goods sold | 50.0M | 57.7M | 59.2M | 105.8M | 126.2M | 101.0M | 86.1M | 92.3M |
| Gross profit | 954.9M | 992.5M | 737.6M | 695.3M | 734.1M | 813.1M | 732.5M | 812.1M |
| Gross profit margin, % | 94.5% | 92.6% | 101.6% | 86.9% | 89.2% | 89.6% | 89.9% | |
| Operating expense total | 694.5M | 754.1M | 599.3M | 547.7M | 573.4M | 644.4M | 574.3M | 580.2M |
| Depreciation and amortization | 34.2M | 47.7M | 29.0M | 31.0M | 33.8M | 36.9M | 139.6M | 37.1M |
| EBITDA | 260.4M | 238.4M | 138.0M | 144.7M | 151.2M | 159.8M | 158.0M | 229.8M |
| EBITDA margin, % | 22.7% | 17.3% | 21.1% | 17.9% | 17.5% | 19.3% | 25.4% | |
| EBIT | 255.8M | 227.9M | 148.5M | 171.5M | 123.5M | 105.7M | 15.4M | 174.4M |
| EBIT margin, % | 21.7% | 18.6% | 25.1% | 14.6% | 11.6% | 1.9% | 19.3% | |
| Interest income | 35.1M | 62.3M | 48.6M | 24.6M | 18.5M | 13.8M | 12.8M | 9.0M |
| Interest expense | 418.0K | 1.4M | 864.0K | 2.4M | 6.2M | 7.5M | ||
| Pre tax profit | 300.2M | 299.1M | 208.0M | 188.9M | 140.3M | 122.7M | 38.9M | 189.7M |
| Income tax expense | 36.3M | 33.0M | 24.7M | 21.4M | 16.4M | (64.8M) | 17.3M | 20.3M |
| Net Income | 263.9M | 266.1M | 183.4M | 167.4M | 123.9M | 187.6M | 21.5M | 169.4M |